Over the 90-day window ending January 02, 2026, Ani Pharmaceuticals's three dominant insider ownership positions are held by Head Of R&D And Coo Novitium Ops Muthusamy Shanmugam (577.50K shares), Svp Corp. Dev. & Strategy Chad Gassert (232.20K shares), Sr. Vp And General Counsel & Sec. Meredith Cook (74.87K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Partners Ii Lp Meridian | 1,819,259 | 16 Aug, 2023 | |
| Muthusamy Shanmugam | Head Of R&D And Coo Novitium Ops | 577,496 | 22 Aug, 2025 |
| Nikhil Lalwani | President & Ceo | 411,219 | 14 Aug, 2025 |
| Chad Gassert | Svp Corp. Dev. & Strategy | 232,199 | 14 Nov, 2025 |
| Stephen P. Carey | Svp & Cfo | 180,863 | 14 Aug, 2025 |
| James G. Marken | Svp Ops & Prod Dev | 117,829 | 11 Jun, 2024 |
| Christopher Mutz | Head Of Rare Disease | 107,317 | 15 May, 2025 |
| Robert W Schrepfer | Svp New Bus Dev & Spec Sales | 87,477 | 29 Mar, 2021 |
| Ori Gutwerg | Svp And Generics | 84,024 | 14 Aug, 2025 |
| Meredith Cook | Sr. Vp And General Counsel & Sec. | 74,874 | 12 Dec, 2025 |
| Krista Davis | Svp And Chief Hr Officer | 58,564 | 19 Dec, 2025 |
| Patrick D Walsh | 58,405 | 17 Nov, 2025 | |
| Robert E. Jr Brown | 49,021 | 29 Apr, 2022 | |
| Thomas Andrew Rowland | Svp And Head Established Brands | 40,794 | 14 Aug, 2025 |
| David Nash | 38,561 | 24 May, 2023 | |
| Thomas Haughey | 36,521 | 14 Aug, 2025 | |
| Renee P Tannenbaum | 25,157 | 09 Dec, 2025 | |
| Jeanne Thoma | 23,405 | 20 Aug, 2025 | |
| Antonio R Pera | 22,660 | 04 Sep, 2025 | |
| Matthew J Leonard | 6,864 | 26 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Dec, 2025 | Krista Davis | Common Stock | D | 1,622 | $82.40 | 58,564 | D | S |
| 12 Dec, 2025 | Meredith Cook | Common Stock | D | 400 | $82.32 | 74,874 | D | S |
| 05 Dec, 2025 | Renee P Tannenbaum | Common Stock | D | 1,800 | $81.15 | 25,157 | D | S |
| 13 Nov, 2025 | Meredith Cook | Common Stock | D | 400 | $87.27 | 75,274 | D | S |
| 13 Nov, 2025 | Patrick D Walsh | Common Stock | D | 8,643 | $86.88 | 61,405 | D | S |
| 13 Nov, 2025 | Patrick D Walsh | Common Stock | D | 3,000 | $0.00 | 58,405 | D | G |
| 12 Nov, 2025 | Chad Gassert | Common Stock | D | 14,642 | $89.07 | 73,615 | D | S |
| 13 Nov, 2025 | Chad Gassert | Common Stock | D | 94 | $88.00 | 158,584 | I | S |
| 13 Oct, 2025 | Meredith Cook | Common Stock | D | 400 | $90.09 | 75,674 | D | S |
| 19 Sep, 2025 | Krista Davis | Common Stock | D | 1,000 | $98.04 | 60,186 | D | S |
| 12 Sep, 2025 | Meredith Cook | Common Stock | D | 400 | $98.42 | 76,074 | D | S |
| 12 Sep, 2025 | Krista Davis | Common Stock | D | 1,710 | $97.71 | 61,186 | D | F |
| 03 Sep, 2025 | Antonio R Pera | Common Stock | D | 7,292 | $94.94 | 22,660 | D | S |
| 25 Aug, 2025 | Matthew J Leonard | Common Stock | D | 2,528 | $90.62 | 6,864 | D | S |
| 22 Aug, 2025 | Krista Davis | Common Stock | D | 1,763 | $91.10 | 62,896 | D | S |
| 20 Aug, 2025 | Antonio R Pera | Common Stock | D | 5,421 | $89.73 | 29,952 | D | S |
| 20 Aug, 2025 | Muthusamy Shanmugam | - | - | 92,588 | D | |||
| 20 Aug, 2025 | Muthusamy Shanmugam | Common Stock | D | 47,012 | $90.27 | 92,588 | D | S |
| 21 Aug, 2025 | Muthusamy Shanmugam | Common Stock | D | 52,988 | $90.44 | 484,908 | I | S |
| 21 Aug, 2025 | Muthusamy Shanmugam | - | - | 484,908 | I |